Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products
First state license is a key achievement as Blue Water continues to expand its business into…
Month: July 2023
Results of Appeal of Delisting Determination
6 July 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Results of Appeal of Delisting Determination…
RobotLAB Expands “AI, Robotics & the Future of Work” Lineup
Highly Anticipated Event to Explore Robotics Integration & Impact from Multidisciplinary Perspectives DALLAS–(BUSINESS WIRE)–RobotLAB, the…
Scope Carbon Announces Secured Loan Facility Agreement with Farm Flight Inc.
Vancouver, British Columbia–(Newsfile Corp. – July 6, 2023) – Scope Carbon Corp. (CSE: SCPE) (OTCQB:…
C&W Returns as Headline Sponsor of CANTO 2023
MIAMI–(BUSINESS WIRE)–Improving the Caribbean’s ability to access connectivity and data will take centre stage at…
T-Mobile is Ready for MLB All-Star Week with Hometown 5G Upgrades
The nation’s 5G leader installed permanent 5G upgrades in T-Mobile Park and across Seattle, enhancing…
Bringing Finance Teams into the Digital Future Is a Hard-Won Battle
By Matthew Debbage, CEO of the Americas and Asia, Creditsafe Digital transformation has been a…
Majesco Enriches Majesco Analytics and Accelerates Implementations With Data Integration Through Qlik
Available to all Majesco Cloud customers this modern data architecture eliminates implementation costs, delays and…
Thorn Technologies Launches SaaS SFTP Service for Cloud Storage with SFTP Gateway Single User Plan
COLUMBIA, Md.–(BUSINESS WIRE)–Thorn Technologies, a leading provider of managed file transfer solutions, has launched their…
22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market
BUFFALO, N.Y., July 06, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a…
TellBio Announces Consecutive Manuscripts Showcasing Promising Translational and Clinical Applications of the TellDx Platform in Prostate Cancer and Tailoring Therapy in Advanced Breast Cancer
— Prostate Circulating Tumor Cells Isolated with TellDx Technology Demonstrates Epigenetic Changes that Silence Immune…
Verizon Business #1 in J.D. Power Small Business Wireline Customer Satisfaction 5th year in a row
NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) — For the fifth consecutive year, Verizon Business…
Government Blockchain Association (GBA) Deploys PlatoAi across GBA’s Opensource Intelligence Platform (OSINT)
Washington, D.C., Jul 6, 2023 – (ACN Newswire) – Government Blockchain Association (GBA) announced the…
KBRA Assigns Rating to Blue Owl Technology Income Corporation’s $100 Million Senior Unsecured Notes due 2026
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns a rating of BBB to Blue Owl Technology Income Corporation’s (“OTIC”…
KBRA Assigns Preliminary Ratings to DT Auto Owner Trust 2023-3
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to five classes of notes issued by DT Auto…
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
Collaboration expands Carrick’s clinical-stage Oncology program DUBLIN, Ireland and BOSTON, July 06, 2023 (GLOBE NEWSWIRE)…
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
Collaboration expands Carrick’s clinical-stage Oncology program DUBLIN, Ireland and BOSTON, July 06, 2023 (GLOBE NEWSWIRE)…
Myriad Genetics Announces New $90 Million Asset-Based Credit Facility
SALT LAKE CITY, July 06, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
Myriad Genetics Announces New $90 Million Asset-Based Credit Facility
SALT LAKE CITY, July 06, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian Cancers
Anti-HER2 and Anti-HER3 monoclonal antibodies designed to have a high drug-to-antibody ratio intended enhance the…